This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,950.29 firm fixed-price delivery order is for the medication Dupixent 300 mg/2 ml pen, with a completion date of November 6, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition. The contract award demonstrates AmerisourceBergen's extensive capabilities in supplying critical medical commodities, including specialty medications, to federal government agencies such as the DLA.
Generated 2/4/25, 10:19 AM